Sarah Lawley · Assistant Deputy Minister, Health Canada (HC)
David Jones · Director, Health Canada (HC)
Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care servicesRead more
AI, with respect to the regulation of AI in financial institutions and insurance, and use and protection of data and information.
Sandenga Yeba · Director of Policy & Deputy Chief of Staff, Health Canada (HC)
Justine Frame · Policy Advisor, Health Canada (HC)
Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care servicesRead more
AI, with respect to the regulation of AI in financial institutions and insurance, and use and protection of data and information.
Daniel MacDonald · Director General, Health Canada (HC)
Margaret Sharp · Director, Health Canada (HC)
Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care servicesRead more
Infrastructure investment, with respect to institutional investment and government partnerships.Read more
Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care services
Jade Mallette · Chief of Staff, Health Canada (HC)
Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care servicesRead more
Greg Orencsak · Deputy Minister, Health Canada (HC)
Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care servicesRead more
Infrastructure investment, with respect to institutional investment and government partnerships.Read more
Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care services
Aaron Wudrick · Director of Policy, House of Commons
Taxation - discussion of taxation policy for financial institutions.Read more
Infrastructure investment, with respect to institutional investment and government partnerships.
Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care services
Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care servicesRead more
Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care servicesRead more
Wayne Long · Secretary of State, Finance Canada (FIN)
Kevin Collins · Chief of Staff, Finance Canada (FIN)
Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care servicesRead more
Infrastructure investment, with respect to institutional investment and government partnerships.
Greg Orencsak · Deputy Minister, Health Canada (HC)
Eric Costen · Associate Deputy Minister, Health Canada (HC)
Jocelyne Voisin · Assistant Deputy Minister, Health Canada (HC)
Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care servicesRead more
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026.
Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month.
Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means.
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence.
PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.